Encainide and metabolites, serum or plasma

Alphabetical Test listing

Encainide and metabolites, serum or plasma-2837

  
Encainide and metabolites, serum or plasma
  
2837
  
LAB2837
  
Encainide
  
Enkaid
  
Encainide
o-Demethylencainide (ODE)
3-Methoxy-o-demethylencainide (MODE)
  

Therapeutic drug management

  
Serum
  
  
1.0 mL
  
0.2 mL
  

Gel-barrier tubes are not recommended.

  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Serum/plasma transfer vial/tube (MedTox), labelled as serum, within two (2) hours of sample collection
  
  
Lithium heparin (Li hep) plasma
Sodium heparin (Na hep) plasma
  

Dk green heparin (Li or Na), no gel

  

  

Immediately following collection, mix sample by inverting 8 - 10 times to prevent clotting

  
  1. Spin
  2. Transfer plasma to aSerum/plasma transfer vial/tube (MedTox), labelled as the appropriate plasma type, within two (2) hours of sample collection
  

Refrigerated (preferred)

Ambient - <3 days

Frozen - OK

  
MedTox Laboratories (176): R-MX
  
Varies
  
7 days
  

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

  

Encainide: 15 - 100 ng/mL

ODE: 100 - 300 ng/mL

MODE: 60 - 300 ng/mL

  

Trough levels are most reproducible.

 

10% of patients do not form therapeutic concentrations of the active metabolites, ODE and MODE. In these patients the recommended range for the encainide concentration is 300 - 1200 ng/mL

  
G0480
  
Yes
  
  
17002425
  
30G04801C
  
11/15/2021
  
12/01/2021